NeutriSci Commences Trading and Provides Corporate Update
December 4, 2014 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE:NU) is pleased to announce that it has commenced trading as a Tier 2 TSX-V issuer under the symbol NU.
NeutriSci is a leader in the innovation, production, formulation and distribution of clinically-studied nutraceutical products. NeutriSci is part of the growing, multi-billion dollar Nutraceutical industry with world-wide distribution channels. NeutriSci has formed a strategic partnership with ChromaDex Corp. (“ChromaDex”) and specializes in products containing pTeroPure® pterostilbene, a patented nutraceutical ingredient developed by ChromaDex. Pterostilibene is a stilbenoid and powerful antioxidant found naturally in blueberries.
NeutriSci acquired the BluScience™ line of products from ChromaDex. The BluScience™ brand includes five retail products that focus on heart health, cognitive function, anti-aging, weight management and energy.
In addition to expanding distribution of the BluScience™ product line throughout the United States retail sector, NeutriSci is also focusing on retail launch campaigns related to its newest product called NeuEnergy™. NeuEnergy™ is an innovative, patent-pending, energy-metabolizing product offering hours of continuous energy with a very low dose of caffeine as compared to energy drinks and shots.
NeuEnergy™ is also designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is typically associated with energy products. The efficacy of NeuEnergy™ is based scientifically on a molecular combination of pTeroPure® pterostilbene and a low dose of caffeine. The resulting co-crystal provides a novel, next-generation alternative to high-dose caffeine products and is the base ingredient of NeuEnergy™. In clinical trials, the co-crystal ingredient demonstrated a significantly longer half-life than caffeine alone.
Glen Rehman, President of NeutriSci, stated: “We are very pleased to be able to initiate our marketing efforts to grow our BluScience™ revenue in addition to launching NeuEnergy™ to the world. NeuEnergy™ is a product that offers consumers the extended boost that they are looking for with responsible ingredients and responsible levels of caffeine all backed by science and clinical trials. Industry and internal studies suggest we have a great opportunity to earn significant market share from this multi-billion dollar industry.”
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
Glen Rehman, President
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men’s prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. For more information, visit: www.neutrisci.com.
NeutriSci International Inc.
Investor Relations Contact:
KIN Communications Inc.
VP Investor Relations